Trending

biostatistics

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

Four years after being taken private, Parexel has been sold again, with Goldman Sachs’ private equity arm and

X

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

https://pharmaphorum.com/news/private-equity-firms-play-pass-the-parexel-with-8-5bn-handover-deal/

The rise of wearable technology for clinical trials: insights from Novartis

The rise of wearable technology for clinical trials: insights from Novartis

The rise of wearable technology for clinical trials

X

The rise of wearable technology for clinical trials: insights from Novartis

https://pharmaphorum.com/partner-content-digital/the-rise-of-wearable-technology-for-clinical-trials-insights-from-novartis/

10th annual Adaptive Designs in Clinical Trials

10th annual Adaptive Designs in Clinical Trials

Adaptive Designs in Clinical Trials 2018

X

10th annual Adaptive Designs in Clinical Trials

https://pharmaphorum.com/events/10th-annual-adaptive-designs-in-clinical-trials/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com